Related Experiment Video
Updated: Jun 3, 2026
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Neonatal hypoglycemia and neurodevelopment outcomes among late preterm infants: a prospective cohort study
Palanikumar Balasundaram1, Nikitha Gorti2, Mariam Latuga3
1Division of Neonatology, Department of Pediatrics, Mercyhealth - Javon Bea Hospital-Riverside, Rockford, IL, USA. dr.palanikumar82@gmail.com.
Insights
Neonatal hypoglycemia in late preterm infants did not affect neurodevelopmental outcomes at 18-24 months. This study supports current American Academy of Pediatrics guidelines for managing infant blood sugar levels.
Area of Science:
- Neonatalogy
- Pediatric Neurology
- Developmental Pediatrics
Background:
- The neurodevelopmental impact of neonatal hypoglycemia in late preterm infants remains unclear.
- Late preterm infants (≥35 weeks' gestation) are a vulnerable population.
- Understanding outcomes is crucial for refining infant care guidelines.
Purpose of the Study:
- To compare neurodevelopmental outcomes at 18-24 months corrected age.
- To assess infants with and without neonatal hypoglycemia in the first 24 hours of life.
- To investigate the specific effects on late preterm infants.
Main Methods:
- A multicenter, prospective cohort study.
- Inclusion of late preterm infants (≥35 weeks gestation, ≥2000g).
- Neurodevelopmental assessment using Bayley Scales of Infant and Toddler Development, Fourth Edition at 18-24 months corrected age.
Main Results:
- No significant neurodevelopmental differences between hypoglycemic and euglycemic cohorts.
- Consistent findings across cognitive, motor, language, social-emotional, and adaptive domains.
- Subgroup analyses for severe or recurrent hypoglycemia also showed no adverse effects.
Conclusions:
- Transient neonatal hypoglycemia, managed per AAP guidelines, is not linked to adverse neurodevelopment in late preterm infants.
- This study provides robust evidence supporting current screening and treatment protocols.
- Findings contribute valuable, population-specific data to the existing literature.
Background:
The impact of neonatal hypoglycemia on neurodevelopment in late preterm infants is not well established. We aimed to compare neurodevelopmental outcomes at 18-24 months' corrected age in a subgroup of late preterm infants who were either euglycemic or hypoglycemic during the initial 24 h of life.
Methods:
We conducted a multicenter, prospective cohort study of a subgroup of late preterm infants (≥35 weeks' gestation and ≥2000 g) who underwent risk-based screening for hypoglycemia in the newborn nursery. Infants were categorized into hypoglycemic and euglycemic cohorts. Neurodevelopment was evaluated at 18-24 months' corrected age using the Bayley Scales of Infant and Toddler Development, Fourth Edition.
Results:
Among 128 infants, no significant differences were observed in neurodevelopmental outcomes at 18-24 months' corrected age between hypoglycemic and euglycemic cohorts. These findings were consistent across cognitive, motor, language, social-emotional, and adaptive behavior domains, even after adjusting for key confounders. Subgroup analyses for severe (<36 mg/dL) and recurrent (≥3 episodes) hypoglycemia did not show any differences in neurodevelopmental outcome.
Conclusion:
Transient neonatal hypoglycemia in late preterm infants, when identified and managed using the American Academy of Pediatrics' operational thresholds, was not associated with adverse neurodevelopmental outcomes at 18-24 months' corrected age.
Impact:
This is one of the few prospective multicenter studies assessing neurodevelopmental outcomes following neonatal hypoglycemia, focused specifically on late preterm infants. Hypoglycemia in late-preterm infants showed no impact on neurodevelopment at 18-24 months. Multicenter design and blinded assessments ensured strong study validity. The study adds population-specific evidence to the existing literature dominated by mixed gestational-age cohorts. Findings support the safety of American Academy of Pediatrics screening guidelines and treatment protocols for managing neonatal hypoglycemia in the newborn nursery.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
01:20Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...